Send us Feedback

OraSure Technologies (OSUR)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
UPDATE: Jefferies Assumes Coverage on OraSure Technologies at Buy on Weaker Demand Trend Concerns
Benzinga  May 31  Comment 
In a report published Friday, Jefferies analyst Brandon Couillard assumed coverage on OraSure Technologies (NASDAQ: OSUR) with a Buy rating, but lowered the price target from $12.00 to $8.00. In the report, Jefferies noted, “Concerns around...
Stocks Hitting 52-Week Lows
Benzinga  Apr 4  Comment 
ZIOPHARM Oncology (NASDAQ: ZIOP) shares fell 1.92% to touch a new 52-week low of $1.53. ZIOPHARM Oncology's trailing-twelve-month ROE is -160.15%. OraSure Technologies (NASDAQ: OSUR) shares reached a new 52-week low of $5.03. OraSure's PEG...
Stocks Hitting 52-Week Lows
Benzinga  Mar 28  Comment 
Garmin (NASDAQ: GRMN) shares touched a new 52-week low of $32.81. Garmin's PEG ratio is 2.08. Aastrom Biosciences (NASDAQ: ASTM) shares reached a new 52-week low of $0.67. Analysts at Needham downgraded Aastrom Biosciences from “buy” to...
Stocks Hitting 52-Week Lows
Benzinga  Feb 11  Comment 
Peregrine Semiconductor (NASDAQ: PSMI) shares touched a new 52-week low of $8.83. Peregrine Semiconductor's trailing-twelve-month profit margin is 3.57%. Anacor Pharmaceuticals (NASDAQ: ANAC) shares fell 3.10% to touch a new 52-week low of...
Stocks Hitting 52-Week Lows
Benzinga  Feb 7  Comment 
OraSure Technologies (NASDAQ: OSUR) shares dropped 9.76% to touch a new 52-week low of $6.34. OraSure issued downbeat Q1 forecast. Accuray (NASDAQ: ARAY) shares touched a new 52-week low of $4.585. Accuray announced proposed offering of $75...
OraSure Technologies, Inc. (OSUR) Tops Q4 EPS by 3c; Issues Light Q1 Outlook
StreetInsider.com  Feb 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/OraSure+Technologies%2C+Inc.+%28OSUR%29+Tops+Q4+EPS+by+3c%3B+Issues+Light+Q1+Outlook/8066652.html for the full story.
OraSure (ORA) Slammed on Lackluster Q4 Outlook
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/OraSure+%28ORA%29+Slammed+on+Lackluster+Q4+Outlook/7857239.html for the full story.
OraSure Technologies, Inc. (OSUR) Tops Q3 EPS by 4c, Guides Q4
StreetInsider.com  Nov 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/OraSure+Technologies%2C+Inc.+%28OSUR%29+Tops+Q3+EPS+by+4c%2C+Guides+Q4/7853863.html for the full story.
(OSUR) OraSure Technologies Unveils In-Home HIV test
Stock Blog Hub  Oct 23  Comment 
OraSure Technologies (OSUR), a provider of medical devices and technologies to diagnose critical medical conditions, recently announced the availability of its OraQuick in-home HIV test at retail outlets and online, across the U.S. The company...
Celebrity Magic Johnson Teams with OraSure (OSUR) to Launch In-Home HIV Test
StreetInsider.com  Oct 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Celebrity+Magic+Johnson+Teams+with+OraSure+%28OSUR%29+to+Launch+In-Home+HIV+Test/7786832.html for the full story.




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Associate
Chris Morrissey

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.




References

Retrieved from "http://www.wikinvest.com/stock/OraSure_Technologies_(OSUR)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki